Marc Lore’s Wonder bets on Texas, automation and user-built restaurants as it mulls IPO
Wonder is leaning into automation and user-built restaurants as founder Marc Lore prepares the startup for a potential IPO.
Stocks, currencies, commodities and the forces moving prices.
Wonder is leaning into automation and user-built restaurants as founder Marc Lore prepares the startup for a potential IPO.
Lawsuits filed by candidate Mary Peltola and a voters' rights group challenge Trump's preemptive efforts to block a Democratic Senate victory in Alaska.
A memo from DNI director Jay Clayton said Iran is in the "advanced stages" of planning attacks against Americans.
Retail investors trying to beat the market by buying individual stocks and complex exchange-traded funds may be better off with broad market index funds.
A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.
Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
As peptides gain popularity among some wellness influencers and federal government officials, doctors share what you need to know.
After almost 18 months, Berkshire Hathaway shares have entirely erased all the ground they lost in the wake of Warren Buffett's surprise announcement at the 2025 shareholders meeting that he would step down as CEO.
Airplanes are getting dismantled for parts years ahead of schedule because engines and other components are in short supply.
As Nvidia has gone from chipmaker to industry financier, some investors see the company taking on outsized risk tied to the AI buildout.
A new CNBC survey finds broad voter opposition to nearby AI data centers, creating a political challenge for Trump and Republicans ahead of the midterm election.
French unrest pushed bond yields to a 24-year high as investors weigh budget, growth and sectors risks ahead of more protests.